Abstract 691: Estrogen receptor mRNA level in breast cancer predicts response to tamoxifen
Jennifer Bordeaux(Lineage Cell Therapeutics (United States)), David L. Rimm(Yale University), Allison Welsh(Yale University), Bruce G. Haffty(Rutgers, The State University of New Jersey), Xiaojun Ma(Advanced Cell Diagnostics (United States)), Huan Cheng(Yale University), Yuling Luo(Guangdong Pharmaceutical University), Donald R. Lannin(Yale University), Xingyong Wu(Quantum Devices (United States)), Nan Su(Army Medical University)
Cited by 0
Related Papers
RNAscope
|Journal of Molecular Diagnostics|2011|2.7k
Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots
|Nature Biotechnology|2002|2.5k
The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements
|Nature Biotechnology|2006|2.2k
PD-L1 as a biomarker of response to immune-checkpoint inhibitors
|Nature Reviews Clinical Oncology|2021|1.5k